BioLine RX Ltd (BLRX) — Capital Reinvestment Ratio
BioLine RX Ltd (BLRX) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow (ILA4.99 Million) in capital expenditures (ILA18.00K). See net asset quality index of BioLine RX Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BioLine RX Ltd Capital Reinvestment Ratio (2010–2010)
This chart tracks BioLine RX Ltd's Capital Reinvestment Ratio across 1 annual periods. Check BLRX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for BioLine RX Ltd (2010–2010)
Year-by-year Capital Reinvestment Ratio for BioLine RX Ltd from 2010 to 2010. For live market cap and broader valuation context, see market cap of BioLine RX Ltd.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.06x | ILA11.46 Million | ILA660.94K | — |